- Medicine Name: Xospata
- Generic Name: Gilteritinib
- Dosage Form & Strength: Tablets: 40 mg
- Manufactured By: Astellas Pharma US, Inc.
Xospata is a kinase inhibitor used for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation.
Recommended Dosage: The recommended starting dose of Xospata tablets is 120 mg orally once daily with or without food. In the absence of disease progression or unacceptable toxicity, treatment for a minimum of six months is recommended to allow time for a clinical response.
Do not break or crush tablets. Administer tablets orally persistently each day. If a dose is missed or not taken at the usual scheduled time, administer the dose of Xospata as promptly as possible on the same day, and at least 12 hours before the very next scheduled dose. Go back with the normal dosing schedule the following day. Do not take a couple of doses within 12 hours.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.